PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 62 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $5,978,000 | +7.5% | 1,607,044 | 0.0% | 0.61% | -15.1% |
| Q1 2021 | $5,560,000 | +3.0% | 1,607,044 | 0.0% | 0.72% | +3.4% |
| Q4 2020 | $5,400,000 | -4.3% | 1,607,044 | 0.0% | 0.70% | -38.7% |
| Q3 2020 | $5,641,000 | -23.7% | 1,607,044 | 0.0% | 1.14% | -21.8% |
| Q2 2020 | $7,392,000 | +39.0% | 1,607,044 | 0.0% | 1.45% | -49.8% |
| Q1 2020 | $5,319,000 | -45.8% | 1,607,044 | 0.0% | 2.90% | -18.2% |
| Q4 2019 | $9,819,000 | – | 1,607,044 | – | 3.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 1,607,044 | $4,194,000 | 0.48% |
| NEA Management Company, LLC | 6,643,704 | $17,340,000 | 0.35% |
| Platform Technology Partners | 251,723 | $657,000 | 0.29% |
| DAFNA Capital Management LLC | 378,611 | $988,000 | 0.25% |
| Avidity Partners Management LP | 4,405,000 | $11,497,000 | 0.24% |
| Endurant Capital Management LP | 360,078 | $940,000 | 0.23% |
| Rock Springs Capital Management LP | 2,581,299 | $6,737,000 | 0.16% |
| RA Capital Management | 2,850,000 | $7,439,000 | 0.13% |
| New Legacy Group, LLC | 240,575 | $628,000 | 0.12% |
| XTX Topco Ltd | 15,574 | $41,000 | 0.02% |